Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Barclays
Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Neurocrine Biosciences Inc Note 2.250 5/1
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by Barclays
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $1.2M | 680k | 1.80 |
2023-12-31 | $974k | 562k | 1.73 |
2023-09-30 | $705k | 475k | 1.48 |
2023-06-30 | $186k | 146k | 1.27 |
2023-03-31 | $120k | 89k | 1.35 |
2022-12-31 | $1.1M | 685k | 1.57 |
2022-09-30 | $731k | 522k | 1.40 |
2022-06-30 | $619k | 465k | 1.33 |
2022-03-31 | $514k | 397k | 1.29 |
2021-12-31 | $921k | 743k | 1.24 |
2021-09-30 | $29k | 22k | 1.32 |
2021-06-30 | $452k | 340k | 1.33 |
2021-03-31 | $405k | 299k | 1.35 |
2020-12-31 | $2.5M | 1.8M | 1.38 |
2020-09-30 | $12M | 8.4M | 1.38 |
2020-03-31 | $2.2M | 1.7M | 1.28 |
2019-09-30 | $0 | 1.4M | 0.00 |
2018-12-31 | $13M | 11M | 1.19 |
2018-09-30 | $6.4M | 3.8M | 1.70 |
2018-06-30 | $870k | 604k | 1.44 |
Top funds holding Neurocrine Biosciences Inc Note 2.250 5/1
View all funds holding Neurocrine Biosciences Inc Note 2.250 5/1